Allyson BerentCSO and COO at Foundation for Angelman Syndrome Therapeutics, GeneTx Biotherapeutics
Agenda Sessions
LIVE SESSION - Leveraging platform approaches to gene therapies to accelerate therapeutic development for monogenic diseases
, 8:30amView Session